Beta-blockers in cirrhosis: Do they have benefits beyond the prevention of variceal bleeding?

Affiliations

Free article

Comment

Senthamizh Selvan et al. Natl Med J India. 2019 Nov-Dec.

Free article

. 2019 Nov-Dec;32(6):355-356.

doi: 10.4103/0970-258X.303615.

¹ Department of Gastroenterology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.

No abstract available

Conflict of interest statement

None

β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.
Villanueva C, Albillos A, Genescà J, Garcia-Pagan JC, Calleja JL, Aracil C, Bañares R, Morillas RM, Poca M, Peñas B, Augustin S, Abraldes JG, Alvarado E, Torres F, Bosch J. Villanueva C, et al. Lancet. 2019 Apr 20;393(10181):1597-1608. doi: 10.1016/S0140-6736(18)31875-0. Epub 2019 Mar 22. Lancet. 2019. PMID: 30910320 Clinical Trial.